The current AWKNF market cap is 2.93M. The company's latest EPS is CAD -0.2609 and P/E is -0.31.
Year End January 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Total Revenue | 246k | 1.5M |
Operating Income | -9.78M | -9.19M |
Net Income | -15.95M | -9.14M |
Year End January 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Total Assets | 6.88M | 4.39M |
Total Liabilities | 3.85M | 4.44M |
Total Equity | 3.02M | -49k |
Year End January 30 2023 | 2022 | 2023 |
---|---|---|
CAD ($) | CAD ($) | |
Operating | -8.59M | -7.36M |
Investing | -1.69M | -95k |
Financing | 11.5M | 6.4M |
Market Cap | 2.93M |
Price to Earnings Ratio | -0.31 |
Price to Sales Ratio | 1.87 |
Price to Cash Ratio | 5.1 |
Price to Book Ratio | -57.21 |
Dividend Yield | - |
Shares Outstanding | 35.04M |
Average Volume (1 week) | 5.56k |
Average Volume (1 Month) | 5.24k |
52 Week Change | -60.14% |
52 Week High | 0.26 |
52 Week Low | 0.0422 |
Spread (Intraday) | 0.1 (57.94%) |
Company Name | Awakn Life Sciences Corporation (QB) |
Address |
301‐217 queen street w toronto, ontario M5V 0R2 |
Website | https://www.awaknlifesciences.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.